Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TLE3 function in rhabdomyosarcoma tumor xenografts.

ABSTRACT: TLE3 function in rhabdomyosarcoma tumor xenografts.

PROVIDER: PRJNA836779 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19154150_1.fastq.gz	Fastqsanger.gz
	SRR19154150_2.fastq.gz	Fastqsanger.gz
	SRR19154151_1.fastq.gz	Fastqsanger.gz
	SRR19154151_2.fastq.gz	Fastqsanger.gz
	SRR19154152_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

TLE3 function in rhabdomyosarcoma tumor xenografts.

Project description:mRNA from control and Tle3 knockout RD (embryonal rhabdomyosarcoma) and SJRH30 (alveolar rhabdomyosarcoma) cell lines xenografted into NOD/SCID mice were subjected to sequencing.

2025-04-25 | GSE202614 | GEO

Longitudinal biopsies of fusion-positive rhabdomyosarcoma orthotopic xenografts

Project description:Longitudinal biopsies of fusion-positive rhabdomyosarcoma orthotopic xenografts

| PRJNA1003123 | ENA

Adipose subtype-selective recruitment of TLE3 in thermogenic gene programs

Project description:Transcriptional effectors of white adipocyte-selective gene expression have not been described. TLE3 is a white-selective cofactor that acts reciprocally with the brown-selective cofactor Prdm16 to specify lipid storage and thermogenic gene programs. When expressed at elevated levels in brown fat, TLE3 counters Prdm16, suppressing brown-selective genes and inducing white-selective genes, resulting in impaired fatty acid oxidation and thermogenesis. To further test the functional consequences of the changes in BAT phenotype in aP2-TLE3 Tg mice, we challenged them with cold exposure at 4C. aP2-TLE3 Tg mice had an impaired ability to respond to cold exposure compared to littermate control mice, as evidenced by a marked drop in core body temperature. Transgenic mice expressing TLE3 from the aP2 enhancer and wild type mice were housed individually without food and bedding immediately before the start of experiments. Mice were allowed free access to water and placed at 4C for 5 hours while core body temperature was monitored every hour using a rectal probe. For microarray experiments of BAT, RNA was extracted and pooled from 4 mice in each group.

2013-09-27 | E-GEOD-51223 | biostudies-arrayexpress

Pax3 loss of function delays tumor progression in kRAS-induced zebrafish rhabdomyosarcoma models

Project description:Pax3 loss of function delays tumor progression in kRAS-induced zebrafish rhabdomyosarcoma models

| PRJNA858992 | ENA

Longitudinal biopsies of fusion-positive rhabdomyosarcoma orthotopic xenografts

Project description:In this experiment, 3 mice were implanted orthotopically with a patient-derived xenograft, SJRHB013759_X14. After tumor engraftment and visible nodule formation, all 3 mice underwent therapy. One mouse received vehicle control (saline), while two mice were treated with a combination of vincristine and irinotecan, to mimic salvage therapy for relapsed rhabdomyosarcoma. Sedated needle biopsies were performed before (time = 0), during therapy (time = 3, 7, and 14 days), and after recurrence.

2024-05-31 | GSE240308 | GEO

We performed ChIP-seq for TLE3 in MDA-MB-453 cells with and without FOXA1 transient silencing (siFOXA1 vs siNS) to determine the requirement of FOXA1 for TLE3 binding.

Project description:The identification of mechanisms controlling breast tumor progression from less aggressive to highly metastatic disease should provide novel therapeutic targets for patients. Here we report the transcriptional corepressor, TLE3, as a critical regulator of cellular plasticity in breast cancer. TLE3 facilitates repression of genes associated with the highly aggressive basal-like breast cancer (BLBC) subtype within luminal cells. Additionally, maintenance of the luminal lineage is dependent on appropriate localization of TLE3 to its transcriptional targets which is mediated through interaction with FOXA1. Furthermore, the ability of TLE3 to repress BLBC transcription results in reduced metastatic capacity and aggressive cellular behaviors. Together our findings establish TLE3 as a critical transcriptional mediator of breast cancer aggressiveness, with TLE3 sustaining the more differentiated and less metastatic nature of luminal tumors through suppression of gene expression programs associated with BLBC.

2023-02-07 | GSE205862 | GEO

Determination of the genome wide binding pattern of TLE3 in luminal breast cancer

2023-02-07 | GSE204667 | GEO

TLE3 drives luminal identity of breast cancer through transcriptional repression of FOXA1-target genes

2023-02-07 | GSE205356 | GEO

Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

Project description:Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

| PRJNA823798 | ENA

Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

Project description:Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma

| PRJNA823799 | ENA